» Articles » PMID: 10713570

Altered MRNA Expression for Brain-derived Neurotrophic Factor and Type II Calcium/calmodulin-dependent Protein Kinase in the Hippocampus of Patients with Intractable Temporal Lobe Epilepsy

Overview
Journal J Comp Neurol
Specialty Neurology
Date 2000 Mar 14
PMID 10713570
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of brain-derived neurotrophic factor and the alpha subunit of calcium/calmodulin-dependent protein kinase II mRNA in hippocampi obtained during surgical resections for intractable temporal lobe epilepsy were examined. Both calcium/calmodulin-dependent protein kinase II and brain-derived neurotrophic factor are localized heavily within the hippocampus and have been implicated in regulating hippocampal activity (Kang and Schuman [1995] Science 267:1658-1662; Suzuki [1994] Intl J Biochem 26:735-744). Also, the autocrine and paracrine actions of brain-derived neurotrophic factor within the central nervous system make it a likely candidate for mediating morphologic changes typically seen in the epileptic hippocampus. Quantitative assessments of mRNA levels in epileptic hippocampi relative to autopsy controls were made by using normalized densitometric analysis of in situ hybridization. In addition, correlations between clinical data and mRNA levels were studied. Relative to autopsy control tissue, decreased hybridization to mRNA of the alpha subunit of calcium/calmodulin-dependent protein kinase II and increased hybridization to brain-derived neurotrophic factor mRNA were found throughout the granule cells of the epileptic hippocampus. There also was a significant negative correlation between the duration of epilepsy and the expression of mRNA for brain-derived neurotrophic factor. These results are similar qualitatively to those found in animal models of epilepsy and suggest that chronic seizure activity in humans leads to persistent alterations in gene expression. Furthermore, these alterations in gene expression may play a role in the etiology of the epileptic condition.

Citing Articles

The effect of acetylcholinesterase inhibitor rivastigmine in pentylenetetrazole-induced kindling model of epilepsy in rats.

Turkdonmez Ak E, Okuyucu B, Hatipoglu B, Arslan G Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39643806 DOI: 10.1007/s00210-024-03679-3.


Molecular Genetics of Acquired Temporal Lobe Epilepsy.

Neumann A, Britsch S Biomolecules. 2024; 14(6).

PMID: 38927072 PMC: 11202058. DOI: 10.3390/biom14060669.


The Possible Role of Brain-derived Neurotrophic Factor in Epilepsy.

AlRuwaili R, Al-Kuraishy H, Al-Gareeb A, Ali N, Alexiou A, Papadakis M Neurochem Res. 2023; 49(3):533-547.

PMID: 38006577 PMC: 10884085. DOI: 10.1007/s11064-023-04064-x.


Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy.

Filimonova E, Pashkov A, Moysak G, Tropynina A, Zhanaeva S, Shvaikovskaya A Front Neurosci. 2023; 17:1217702.

PMID: 37539386 PMC: 10395949. DOI: 10.3389/fnins.2023.1217702.


Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy.

Martins-Ferreira R, Leal B, Chaves J, Ciudad L, Samoes R, Martins da Silva A Clin Epigenetics. 2022; 14(1):188.

PMID: 36575526 PMC: 9795776. DOI: 10.1186/s13148-022-01416-2.